Tango Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Tango Therapeutics generated cash of -$117,982,000, which is less than the previous year. Cash used in financing activities reached the amount of $82,406,000 last year. Net change in cash is therefore $5,850,000.
Cash Flow
| 2019 | -24.80M | 848K | 11M |
|---|---|---|---|
| 2020 | 70.07M | -145.46M | 80.88M |
| 2021 | -59.52M | -183.43M | 357.32M |
| 2022 | -109.08M | 26.39M | 1.61M |
| 2023 | -117.98M | 41.42M | 82.40M |
TNGX Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 63.95M | 145.02M | 30.66M | 25.16M | 0 |
Operating activities | |||||
Net income | -101.74M | -108.17M | -58.23M | -51.97M | -14.09M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 2.41M | 1.60M | 897K | 718K | 643K |
Stock-based compensation expense | 19.07M | 14.23M | 7.83M | 1.76M | 1.69M |
| Deferred income tax benefit | 19.07M | 14.23M | 7.83M | 1.76M | 1.69M |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 2M | 0 | 0 | -2M | 0 |
Inventories | 0 | 0 | 0 | 422K | 0 |
Accounts payable | -1.70M | 1.09M | 1.23M | 1.17M | 0 |
Cash generated by operating activities | -117.98M | -109.08M | -59.52M | 70.07M | -24.80M |
Investing activities | |||||
Purchases Of Investments | -310.57M | -208.50M | -372.36M | -207.54M | 0 |
Investments In Property Plant And Equipment | -1.52M | -7.69M | -1.83M | -1.10M | -1.81M |
Acquisitions Net | 0 | -34.09M | 181.59M | 0 | 0 |
Cash generated by investing activities | 41.42M | 26.39M | -183.43M | -145.46M | 848K |
Financing activities | |||||
Common Stock Issued | 80.01M | 1.62M | 29.99M | 80.88M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -342.11M | -655K | 0 |
Cash used in financing activities | 82.40M | 1.61M | 357.32M | 80.88M | 11M |
Net Change In Cash | 5.85M | -81.06M | 114.36M | 5.49M | 25.16M |
Cash at end of period | 69.80M | 63.95M | 145.02M | 30.66M | 25.16M |
| Data source | Data source | Data source | Data source |